Precision Biosciences (DTIL) Interest & Investment Income (2018 - 2026)
Precision Biosciences (DTIL) reported Interest & Investment Income of $999000.0 for Q1 2026, down 24.49% year-over-year from $1.3 million in Q1 2025, and up 29.24% quarter-over-quarter from $773000.0 in Q4 2025.
Precision Biosciences (DTIL) Interest & Investment Income (2018 - 2026) Analysis & Trends
Precision Biosciences (DTIL) has 9 years of Interest & Investment Income data on file, last reported at $999000.0 in Q1 2026.
- Interest & Investment Income for Q1 2026 came in at $999000.0, down 24.49% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.9 million (down 39.05% YoY), and the FY2025 annual result was $4.2 million, down 37.32% from the prior year.
- Interest & Investment Income rose to $999000.0 in Q1 2026 per DTIL's latest filing, from $773000.0 in the prior quarter.
- Over five years, Interest & Investment Income peaked at $2.0 million in Q1 2023 and troughed at $172000.0 in Q1 2022.
- A 5-year average of $1.4 million and a median of $1.5 million in 2024 frame the typical range for Interest & Investment Income.
- The sharpest annual moves came in 2022 and 2025: Interest & Investment Income jumped 2974.6% in 2022, then tumbled 48.26% in 2025.
- A 5-year view of Interest & Investment Income shows it stood at $1.9 million in 2022, then fell by 5.68% to $1.8 million in 2023, then retreated by 18.23% to $1.5 million in 2024, then plunged by 48.26% to $773000.0 in 2025, then increased by 29.24% to $999000.0 in 2026.
- Business Quant data shows DTIL's Interest & Investment Income at $999000.0 in Q1 2026, $773000.0 in Q4 2025, and $1.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 597,319.59 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 40.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 305,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 103,341.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 114.80 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -14.79 Mn |
| 10 | Precision Biosciences | 168.99 Mn | 67.81 Mn | - | 999,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 999,000.00 |
| Dec 31, 2025 | 773,000.00 |
| Sep 30, 2025 | 1.03 Mn |
| Jun 30, 2025 | 1.12 Mn |
| Mar 31, 2025 | 1.32 Mn |
| Dec 31, 2024 | 1.49 Mn |
| Sep 30, 2024 | 1.76 Mn |
| Jun 30, 2024 | 1.84 Mn |
| Mar 31, 2024 | 1.66 Mn |
| Dec 31, 2023 | 1.83 Mn |
| Sep 30, 2023 | 1.87 Mn |
| Jun 30, 2023 | 1.95 Mn |
| Mar 31, 2023 | 2.04 Mn |
| Dec 31, 2022 | 1.94 Mn |
| Sep 30, 2022 | 1.17 Mn |
| Jun 30, 2022 | 192,000.00 |
| Mar 31, 2022 | 172,000.00 |
| Dec 31, 2021 | 63,000.00 |
| Sep 30, 2021 | 44,000.00 |
| Jun 30, 2021 | 48,000.00 |